Panbela Therapeutics, Inc. PBLA on OTC
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
Business address:
712 VISTA BLVD #305, WACONIA, MN, 55387
Phone: 9524791196
712 VISTA BLVD #305, WACONIA, MN, 55387
Phone: 9524791196
Mailing address:
712 VISTA BLVD #305, WACONIA, MN, 55387
712 VISTA BLVD #305, WACONIA, MN, 55387
Category:
Non-accelerated filer
Smaller reporting company
Non-accelerated filer
Smaller reporting company
Former names:
- Sun BioPharma, Inc. - filings through 2020-12-02
- Cimarron Medical, Inc. - filings through 2015-09-04
- CIMARRON SOFTWARE INC - filings through 2015-05-26
Filings:
579 EDGAR filings since May 14, 2012
579 EDGAR filings since May 14, 2012
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- January 10, 2025 - S-8: Securities to be offered to employees in employee benefit plansOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 18, 2024 - 424B3: Prospectus [Rule 424(b)(3)]Open documentClick to Open document FilingOpen filingClick to Open filing
- November 18, 2024 - 424B3: Prospectus [Rule 424(b)(3)]Open documentClick to Open document FilingOpen filingClick to Open filing
- November 18, 2024 - 424B3: Prospectus [Rule 424(b)(3)]Open documentClick to Open document FilingOpen filingClick to Open filing
- November 18, 2024 - 424B3: Prospectus [Rule 424(b)(3)]Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- November 18, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 2.03 - Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 3.02 - Unregistered Sales of Equity Securities
- 5.01 - Changes in Control of Registrant
- 9.01 - Financial Statements and Exhibits
- November 14, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- October 28, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 2.03 - Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 3.02 - Unregistered Sales of Equity Securities
- 9.01 - Financial Statements and Exhibits
- September 27, 2024 - 8-K: Current reportOpen documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- November 14, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 13, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 15, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- March 26, 2024 - 10-K: Annual report for year ending December 31, 2023Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- May 6, 2024 - DEFR14A: Revised definitive proxy soliciting materialsOpen documentClick to Open document FilingOpen filingClick to Open filing
- April 26, 2024 - PRER14A: Preliminary Proxy Soliciting materialsOpen documentClick to Open document FilingOpen filingClick to Open filing
- April 4, 2024 - DEF 14A: Other definitive proxy statementsOpen documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- November 19, 2024 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- October 29, 2024 - 3: Initial statement of beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- October 3, 2024 - 4: Statement of changes in beneficial ownership of securitiesOpen documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- October 29, 2024 - SC 13D: General Statement of Acquisition of Beneficial OwnershipOpen documentClick to Open document FilingOpen filingClick to Open filing
- February 13, 2024 - SC 13G/A: Statement of Beneficial Ownership by Certain Investors - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
Form type | Form description | Filing date | Reporting date |
---|
0
Showing 1 to 432 of 579 entries
Data source:
CIK0001029125.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors